Article and Video CATEGORIES

Cancer Journey

Search By

ABOUT
Denise Brock

Denise has over 30 years of varying experience in the healthcare arena.  In August 2009 she joined The Global Resource for Advancing Cancer Education as one of its first employees.  She has grown with the organization and now oversees the operational movement of programs, efficiency, and effectiveness within the organization, as well as the daily processes and functions.  

 

OncTalk 2022 - A Live Online Patient Education Event
dbrock
Author
Denise Brock
Image
OncTalk 2022 Lung

Please join us for OncTalk 2022 


This is a FREE online event for lung cancer patients, caregivers, and survivors, with the opportunity to interact with several world-class lung cancer oncologists, hear the latest information on treatments and participate in a Q&A session with doctors during this live, virtual event.

 

The program will be held as an online event on Saturday, December 10, 2022 from 11am-1:30pm Eastern Time, 8am - 10:30am Pacific Time.


This program will be broadcast as a live, online event, and viewers of the Livestream will be able to submit questions online during the program.

If you or someone you know is a lung cancer patient or survivor, don't miss this opportunity to learn from leading oncologists and have the opportunity to ask questions of these experts. There is no fee but seats are limited and registration is recommended.

Join us on December 10! 


 

The Agenda can be found here: https://cancergrace.org/onctalk-2022-agenda

The Faculty Bios can be found here: https://cancergrace.org/onctalk-2022-faculty

And you can Register Here Now! 

 


A huge thank you to our sponsor!
Image
Takeda Oncology

 

Video Language

Next Previous link

Previous PostNext Post

Related Content

Online Community

A Brief Tornado.  I love the analogy Dr. Antonoff gave us to describe her presentation.  I felt it earlier too and am looking forward to going back for deeper dive.

Dr. Singhi's reprise about appropriate treatment, "Right patient, right time, right team".

 

An antibody–drug conjugate (ADC) works a bit like a Trojan horse. It has three main components:

  1. The antibody, which serves as the “horse,” specifically targets a protein found on cancer...

Bispecifics, or bispecific antibodies, are advanced immunotherapy drugs engineered to have two binding sites, allowing them to latch onto two different targets simultaneously, like a cancer cell and a T-cell, effectively...

The prefix “oligo–” means few. Oligometastatic (at diagnosis) Oligoprogression (during treatment)

There will be a discussion, “Studies in Oligometastatic NSCLC: Current Data and Definitions,” which will focus on what we...

Radiation therapy is primarily a localized treatment, meaning it precisely targets a specific tumor or area of the body, unlike systemic treatments (like chemotherapy) that affect the whole body.

The...

Biomarkers are genetic mutations (like EGFR, ALK, KRAS, BRAF) or protein levels (like PD-L1) in tumor cells that help guide personalized treatment, especially NSCLC, directing patients to targeted therapies or immunotherapies...

Recent Comments

JOIN THE CONVERSATION
Right patient, right time,…
By JanineT GRACE … on
A Brief Tornado.  I love the…
By JanineT GRACE … on
Biomarkers
By JanineT GRACE … on
Radiation Therapy
By JanineT GRACE … on